These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31864114)
41. Preparation and characterization of bolaform surfactant vesicles. Muzzalupo R; Trombino S; Iemma F; Puoci F; La Mesa C; Picci N Colloids Surf B Biointerfaces; 2005 Dec; 46(2):78-83. PubMed ID: 16257519 [TBL] [Abstract][Full Text] [Related]
42. Stability of niosomes with encapsulated vitamin D3 and ferrous sulfate generated using a novel supercritical carbon dioxide method. Wagner ME; Spoth KA; Kourkoutis LF; Rizvi SS J Liposome Res; 2016 Dec; 26(4):261-8. PubMed ID: 26585564 [TBL] [Abstract][Full Text] [Related]
43. Cationic niosomes composed of spermine-based cationic lipids mediate high gene transfection efficiency. Paecharoenchai O; Niyomtham N; Ngawhirunpat T; Rojanarata T; Yingyongnarongkul BE; Opanasopit P J Drug Target; 2012 Nov; 20(9):783-92. PubMed ID: 22931523 [TBL] [Abstract][Full Text] [Related]
44. Formulation of resveratrol entrapped niosomes for topical use. Pando D; Matos M; Gutiérrez G; Pazos C Colloids Surf B Biointerfaces; 2015 Apr; 128():398-404. PubMed ID: 25766923 [TBL] [Abstract][Full Text] [Related]
45. Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes. Ruckmani K; Sankar V; Sivakumar M J Biomed Nanotechnol; 2010 Feb; 6(1):43-51. PubMed ID: 20499831 [TBL] [Abstract][Full Text] [Related]
46. Development, manufacture and characterization of niosomes for the delivery for nevirapine. Witika BA; Walker RB Pharmazie; 2019 Feb; 74(2):91-96. PubMed ID: 30782257 [TBL] [Abstract][Full Text] [Related]
47. Vitamin D3 Loaded Niosomes and Transfersomes Produced by Ethanol Injection Method: Identification of the Critical Preparation Step for Size Control. Estupiñan OR; Garcia-Manrique P; Blanco-Lopez MDC; Matos M; Gutiérrez G Foods; 2020 Sep; 9(10):. PubMed ID: 32993064 [TBL] [Abstract][Full Text] [Related]
48. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes. Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778 [TBL] [Abstract][Full Text] [Related]
49. Niosomes as Nano-Delivery Systems in the Pharmaceutical Field. Cerqueira-Coutinho C; Dos Santos EP; Mansur CR Crit Rev Ther Drug Carrier Syst; 2016; 33(2):195-212. PubMed ID: 27651102 [TBL] [Abstract][Full Text] [Related]
50. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles. Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277 [TBL] [Abstract][Full Text] [Related]
51. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation. Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876 [TBL] [Abstract][Full Text] [Related]
52. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Bendas ER; Abdullah H; El-Komy MH; Kassem MA Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035 [TBL] [Abstract][Full Text] [Related]
53. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Abd-Elbary A; El-laithy HM; Tadros MI Int J Pharm; 2008 Jun; 357(1-2):189-98. PubMed ID: 18339494 [TBL] [Abstract][Full Text] [Related]
54. Examination of the effect of niosome preparation methods in encapsulating model antigens on the vesicle characteristics and their ability to induce immune responses. Obeid MA; Teeravatcharoenchai T; Connell D; Niwasabutra K; Hussain M; Carter K; Ferro VA J Liposome Res; 2021 Jun; 31(2):195-202. PubMed ID: 32396752 [TBL] [Abstract][Full Text] [Related]
55. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Muzzalupo R; Tavano L; Cassano R; Trombino S; Ferrarelli T; Picci N Eur J Pharm Biopharm; 2011 Sep; 79(1):28-35. PubMed ID: 21303691 [TBL] [Abstract][Full Text] [Related]
56. PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides. Huang Y; Chen J; Chen X; Gao J; Liang W J Mater Sci Mater Med; 2008 Feb; 19(2):607-14. PubMed ID: 17619962 [TBL] [Abstract][Full Text] [Related]
57. Preparation of curcuminoid niosomes for enhancement of skin permeation. Rungphanichkul N; Nimmannit U; Muangsiri W; Rojsitthisak P Pharmazie; 2011 Aug; 66(8):570-5. PubMed ID: 21901978 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery. Alsarra IA J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197 [TBL] [Abstract][Full Text] [Related]
59. In-vivo disposition characteristics of PEG niosome and its interaction with serum proteins. Shehata T; Kimura T; Higaki K; Ogawara KI Int J Pharm; 2016 Oct; 512(1):322-328. PubMed ID: 27586409 [TBL] [Abstract][Full Text] [Related]
60. Design and characterization of ofloxacin niosomes. Ramalingam N; Natesan G; Dhandayuthapani B; Perumal P; Balasundaram J; Natesan S Pak J Pharm Sci; 2013 Nov; 26(6):1089-96. PubMed ID: 24191311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]